Answers are grounded in this paper and cite their sources.
Cycloheximide is an antimitotic and an inhibitor of the synthesis of both DNA and protein. Topical application in low concentrations (0.1%-0.2%) resulted in definite involution of psoriatic plaques. Because of its potency this experimental drug - not yet available for clinical use - was employed on small areas only and with extreme caution. Results of a full evaluation for safety, currently in progress, are being awaited with interest.
No takes yet. Share an insight, caveat, or question.
Leopoldo F. Montes (1976) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: